Gastrointestinal Molecular Diagnostics Market: By Technology, By Disease Indication, By Application, By End-users and Region Forecast 2020-2031
Gastrointestinal Molecular Diagnostics Market size was valued at US$ 155.40 million in 2024 and is expected to reach US$ 199.05 million by 2031, growing at a significant CAGR of 3.6% from 2025-2031. The market is anticipated to witness significant growth in the coming years, driven by several factors, such as the rising prevalence of gastrointestinal diseases, technological advancement (next-generation sequencing and PCR), growing awareness of the benefits of molecular diagnostics, and additionally supportive government policies around the world are creating a fertile ground for the market to flourish. Which empowers doctors to pinpoint and characterize genetic mutations linked to gastrointestinal diseases with exceptional precision and sensitivity. This, coupled with the growing need for early diagnoses and personalized treatments, which driving the market demand in the fight against gastrointestinal ailments.
Study Period
2025-2031Base Year
2024CAGR
3.6%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The market is expected to continue its growth trajectory in the coming years, driven by the increasing burden of gastrointestinal diseases according to the University of Gothenburg, in every ten adults in the world, four suffer from GIDs of varying severity, technological advancements in molecular biology techniques, such as next-generation sequencing (NGS) are leading to the development of more specific and sensitive diagnostic tests, and a growing emphasis on personalized medicine. However, addressing challenges related to cost and regulatory hurdles will be crucial for sustained market expansion.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The Asia-Pacific is the fastest growing due to the untapped market and increased cost-effective diagnosis solutions. In addition, the large pool of patients with a rising geriatric population in the region, and the increase in R&D activities related to gastrointestinal diseases will fuel segment growth. North America is a dominating market for gastrointestinal (GI) disorders and is expected to grow significantly due to several factors. These include the high prevalence of GI issues, rising public awareness of these conditions, and the well-established healthcare infrastructure in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 155.40 million |
|
Market Size in 2031 |
US$ 199.05 million |
|
Market CAGR |
3.6% |
|
By Technology |
|
|
By Disease Indication |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
The gastrointestinal molecular diagnostics market size was valued at US$ 155.40 million in 2024 and is projected to grow at a CAGR of 3.6% from 2025-2031.
F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation (Cepheid), Hologic, bioMérieux SA, Illumina, Inc., QIAGEN, BD, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc.., Grifols, S.A., Siemens Healthineers AG, and Sysmex Corporation.
Asia-Pacific is the fastest growing region for market.
| 1.Executive Summary |
| 2.Global Gastrointestinal Molecular Diagnostics Market Introduction |
| 2.1.Global Gastrointestinal Molecular Diagnostics Market - Taxonomy |
| 2.2.Global Gastrointestinal Molecular Diagnostics Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Disease Indication |
| 2.2.3.Application |
| 2.2.4.End User |
| 2.2.5.Region |
| 3.Global Gastrointestinal Molecular Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Gastrointestinal Molecular Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Gastrointestinal Molecular Diagnostics Market By Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Polymer Chain Reaction, |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Next-Generation Sequencing |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Gastrointestinal Molecular Diagnostics Market By Disease Indication, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Viruses, |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bacteria, and |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Parasite |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Gastrointestinal Molecular Diagnostics Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Infectious Diseases, |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Gastrointestinal Cancers |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global Gastrointestinal Molecular Diagnostics Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Hospital & Clinics |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Research Institution |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Laboratories |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Gastrointestinal Molecular Diagnostics Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Gastrointestinal Molecular Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Polymer Chain Reaction, |
| 10.1.2.Next-Generation Sequencing |
| 10.2. Disease Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viruses, |
| 10.2.2.Bacteria, and |
| 10.2.3.Parasite |
| 10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Infectious Diseases, |
| 10.3.2.Gastrointestinal Cancers |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital & Clinics |
| 10.4.2.Research Institution |
| 10.4.3.Diagnostic Laboratories |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Gastrointestinal Molecular Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Polymer Chain Reaction, |
| 11.1.2.Next-Generation Sequencing |
| 11.2. Disease Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viruses, |
| 11.2.2.Bacteria, and |
| 11.2.3.Parasite |
| 11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Infectious Diseases, |
| 11.3.2.Gastrointestinal Cancers |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital & Clinics |
| 11.4.2.Research Institution |
| 11.4.3.Diagnostic Laboratories |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Gastrointestinal Molecular Diagnostics Market 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Polymer Chain Reaction, |
| 12.1.2.Next-Generation Sequencing |
| 12.2. Disease Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viruses, |
| 12.2.2.Bacteria, and |
| 12.2.3.Parasite |
| 12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Infectious Diseases, |
| 12.3.2.Gastrointestinal Cancers |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital & Clinics |
| 12.4.2.Research Institution |
| 12.4.3.Diagnostic Laboratories |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Gastrointestinal Molecular Diagnostics Market 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Polymer Chain Reaction, |
| 13.1.2.Next-Generation Sequencing |
| 13.2. Disease Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viruses, |
| 13.2.2.Bacteria, and |
| 13.2.3.Parasite |
| 13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Infectious Diseases, |
| 13.3.2.Gastrointestinal Cancers |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital & Clinics |
| 13.4.2.Research Institution |
| 13.4.3.Diagnostic Laboratories |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Gastrointestinal Molecular Diagnostics Market 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Polymer Chain Reaction, |
| 14.1.2.Next-Generation Sequencing |
| 14.2. Disease Indication Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Viruses, |
| 14.2.2.Bacteria, and |
| 14.2.3.Parasite |
| 14.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Infectious Diseases, |
| 14.3.2.Gastrointestinal Cancers |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospital & Clinics |
| 14.4.2.Research Institution |
| 14.4.3.Diagnostic Laboratories |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Hoffmann-La Roche AG |
| 15.2.2.Abbott Laboratories |
| 15.2.3.Danaher Corporation (Cepheid) |
| 15.2.4.Hologic, Inc. |
| 15.2.5.bioMérieux SA |
| 15.2.6.Illumina, Inc. |
| 15.2.7.QIAGEN |
| 15.2.8.BD |
| 15.2.9.Bio-Rad Laboratories, Inc. |
| 15.2.10.Agilent Technologies, Inc. |
| 15.2.11.Illumina, Inc. |
| 15.2.12.Grifols, S.A. |
| 15.2.13.Siemens Healthineers AG |
| 15.2.14.Sysmex Corporation |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
